Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AnaConDa-50ml versus AnaConDa-100ml for sedation of invasively ventilated patients
DRKS00020240Phase 3Completed
- Sponsor
- Sedana Medical
- Start
- Jan 2020
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial of isoflurane and propofol in acute respiratory decompensation and critical illness (3 arms), sponsored by Sedana Medical. Started Jan 2020; status: completed.
02
Drugs
isofluranepropofol
03
Conditions
acute respiratory decompensationcritical illness
Beyond the preview
Go deeper on DRKS00020240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020240.